Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
CI 
Cigna Corp (CI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/16/2025: CI (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
25 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $369.13
1 Year Target Price $369.13
| 13 | Strong Buy |
| 6 | Buy |
| 6 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -9.35% | Avg. Invested days 33 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/16/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 79.31B USD | Price to earnings Ratio 16.61 | 1Y Target Price 369.13 |
Price to earnings Ratio 16.61 | 1Y Target Price 369.13 | ||
Volume (30-day avg) 25 | Beta 0.49 | 52 Weeks Range 255.60 - 355.46 | Updated Date 09/16/2025 |
52 Weeks Range 255.60 - 355.46 | Updated Date 09/16/2025 | ||
Dividends yield (FY) 1.92% | Basic EPS (TTM) 17.89 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 1.92% | Operating Margin (TTM) 3.67% |
Management Effectiveness
Return on Assets (TTM) 3.98% | Return on Equity (TTM) 13.18% |
Valuation
Trailing PE 16.61 | Forward PE 9.32 | Enterprise Value 107254143987 | Price to Sales(TTM) 0.31 |
Enterprise Value 107254143987 | Price to Sales(TTM) 0.31 | ||
Enterprise Value to Revenue 0.41 | Enterprise Value to EBITDA - | Shares Outstanding 266928000 | Shares Floating 265638812 |
Shares Outstanding 266928000 | Shares Floating 265638812 | ||
Percent Insiders 1.59 | Percent Institutions 90.15 |
Upturn AI SWOT
Cigna Corp
Company Overview
History and Background
Cigna Corp was formed in 1982 through the merger of INA Corporation and Connecticut General Corporation. INA, founded in 1792, was the Insurance Company of North America, while Connecticut General was a life insurance company founded in 1865. Over time, Cigna has grown through acquisitions and expansions into various healthcare services.
Core Business Areas
- Evernorth: Evernorth encompasses Cigna's health services businesses, including pharmacy benefit management (PBM) through Express Scripts, specialty pharmacy, and care delivery and management solutions.
- Cigna Healthcare: Cigna Healthcare provides medical, dental, and behavioral health coverage to employers, individuals, and families. This segment includes commercial and government-sponsored plans (Medicare Advantage, Medicaid).
- International Health: Provides medical, dental, and supplemental health benefits for globally mobile individuals and employees of multinational organizations.
Leadership and Structure
David Cordani serves as the Chairman and CEO of Cigna Corp. The company operates with a functional organizational structure, with leadership teams overseeing each major business segment and corporate functions.
Top Products and Market Share
Key Offerings
- Group Medical Insurance: Provides medical coverage to employer-sponsored health plans. Competitors: UnitedHealth Group, Anthem, Aetna (CVS Health), Humana.
- Pharmacy Benefit Management (PBM): Through Express Scripts, Cigna manages prescription drug benefits for health plans, employers, and government entities. Competitors include CVS Health (Caremark) and UnitedHealth Group (OptumRx). Market share of Cigna in PBM is estimated around 25%.
- Medicare Advantage Plans: Offers Medicare Advantage plans to seniors. Competitors include UnitedHealth Group, Humana, and CVS Health. Number of Cigna customers with Medicare Advantage is estimated around 600k.
- Specialty Pharmacy: Provides specialty medications and services for complex conditions. Competitors include CVS Health and UnitedHealth Group.
Market Dynamics
Industry Overview
The healthcare industry is characterized by increasing costs, regulatory changes (e.g., Affordable Care Act), and a focus on value-based care. Key trends include consolidation, digital health solutions, and personalized medicine.
Positioning
Cigna is a diversified health services company with a strong presence in both insurance and pharmacy benefit management. Its competitive advantages include its scale, integrated services, and focus on customer experience.
Total Addressable Market (TAM)
The TAM for healthcare in the US is estimated to be in the trillions of dollars annually. Cigna is positioned to capture a significant share of this TAM through its diversified offerings and strategic partnerships.
Upturn SWOT Analysis
Strengths
- Diversified business model
- Strong PBM capabilities through Evernorth
- Large customer base
- Strong financial performance
- Well-established brand
Weaknesses
- Exposure to regulatory changes
- Integration risks associated with acquisitions
- Complex organizational structure
- Dependence on key contracts
- Negative publicity regarding PBM practices
Opportunities
- Expansion into new markets
- Growth in Medicare Advantage
- Increased demand for telehealth services
- Partnerships with healthcare providers
- Innovation in digital health
Threats
- Increasing competition
- Healthcare reform
- Rising healthcare costs
- Cybersecurity risks
- Economic downturn
Competitors and Market Share
Key Competitors
- UNH
- CVS
- HUM
- ANTM
Competitive Landscape
Cigna competes with other large, diversified health services companies. Its strengths include its PBM capabilities and focus on customer experience. Weaknesses include its exposure to regulatory changes and integration risks.
Major Acquisitions
Express Scripts
- Year: 2018
- Acquisition Price (USD millions): 67000
- Strategic Rationale: Acquisition of Express Scripts enhanced Cigna's PBM capabilities, creating a more integrated healthcare services company.
Growth Trajectory and Initiatives
Historical Growth: Cigna has experienced growth through acquisitions and organic expansion. The acquisition of Express Scripts in 2018 significantly expanded its PBM capabilities. Historical growth rates will be added once current/recent information is readily available to maintain accuracy.
Future Projections: Analysts project continued growth for Cigna, driven by its diversified business model and expansion into new markets. Future projections will be added once current/recent information is readily available to maintain accuracy.
Recent Initiatives: Recent initiatives include expanding its Medicare Advantage offerings, investing in digital health solutions, and focusing on value-based care.
Summary
Cigna is a diversified health services company with a strong PBM business through Evernorth and a significant presence in insurance. Its growth is driven by Medicare Advantage and digital health initiatives. Regulatory changes and increasing competition pose challenges, but its diversified model and integrated services provide a competitive advantage. Overall it is a strong company, but needs to keep a close eye on regulatory changes. It is also well-positioned for further growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Analyst Reports
- Market Research Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market data is subject to change. This analysis is based on publicly available information and may not be exhaustive.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cigna Corp
Exchange NYSE | Headquaters Bloomfield, CT, United States | ||
IPO Launch date 1982-03-31 | CEO & Chair of the Board Mr. David Michael Cordani | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 71295 | Website https://www.cigna.com |
Full time employees 71295 | Website https://www.cigna.com | ||
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations and stop loss insurance. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.